Patents by Inventor Chandra A. Prakash

Chandra A. Prakash has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Metabolites of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid
    Patent number: 6852863
    Abstract: The present invention relates to metabolites of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid.
    Type: Grant
    Filed: January 29, 2003
    Date of Patent: February 8, 2005
    Assignee: Pfizer Inc.
    Inventors: Kimberly O. Cameron, Kim A. Johnson, Bruce A. Lefker, Chandra A. Prakash
  • Metabolites of (3-[[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid
    Publication number: 20030216445
    Abstract: The present invention relates to metabolites of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid.
    Type: Application
    Filed: January 29, 2003
    Publication date: November 20, 2003
    Inventors: Kimberly O. Cameron, Kim A. Johnson, Bruce A. Lefker, Chandra A. Prakash
  • Estrogen agonist/antagonist metabolites
    Patent number: 6455572
    Abstract: This invention relates to compounds that are mammalian metabolites of (−)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol. The compounds of the invention can be used as standards for analytical assays or as intermediates for the further chemical synthesis or biosynthesis of chemical entities. The invention also relates to pharmaceutical compositions for the treatment of disease and methods of treating disease.
    Type: Grant
    Filed: April 4, 2001
    Date of Patent: September 24, 2002
    Assignee: Pfizer Inc.
    Inventors: Wesley W. Day, Kim A. Johnson, Chandra A. Prakash, James F. Eggler
  • Estrogen agonist / antagonist metabolites
    Publication number: 20020042443
    Abstract: This invention relates to compounds that are mammalian metabolites of (−)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol. The compounds of the invention can be used as standards for analytical assays or as intermediates for the further chemical synthesis or biosynthesis of chemical entities. The invention also relates to pharmaceutical compositions for the treatment of disease and methods of treating disease.
    Type: Application
    Filed: April 4, 2001
    Publication date: April 11, 2002
    Inventors: Wesley W. Day, Kim A. Johnson, Chandra A. Prakash, James F. Eggler
  • Estrogen agonist/antagonist metabolites
    Patent number: RE39419
    Abstract: This invention relates to compounds that are mammalian metabolites of (?)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol. The compounds of the invention can be used as standards for analytical assays or as intermediates for the further chemical synthesis or biosynthesis of chemical entities. The invention also relates to pharmaceutical compositions for the treatment of disease and methods of treating disease.
    Type: Grant
    Filed: May 30, 2003
    Date of Patent: December 5, 2006
    Assignee: Pfizer Inc.
    Inventors: Wesley W. Day, Kim A. Johnson, Chandra A. Prakash, James F. Eggler